Inflammation- and immunity-related pathways

Inflammation- and immunity-related pathways encompass a diverse and complex set of signaling networks, such as the JAK-STAT, NF-κB, and Toll-like receptor pathways, that govern the body's defense mechanisms and inflammatory responses (Source: Nature Reviews Immunology). These pathways are essential for pathogen clearance and wound healing; however, their chronic dysregulation is a primary driver of inflammatory conditions, autoimmune disorders, and the progression of certain cancers (Source: NIH/NCBI). Because this term refers to a broad functional category involving hundreds of distinct proteins and receptors, it does not constitute a single, specific therapeutic target. Instead, pharmacological agents are designed to inhibit or activate specific molecular components within these pathways to achieve therapeutic effects (Source: StatPearls). Common therapeutic strategies include the use of monoclonal antibodies to neutralize specific cytokines or small molecules to inhibit specific intracellular enzymes that mediate these signals.

Other names

Immune signaling pathwaysInflammatory pathwaysImmune system pathways

Drugs targeting these pathways act through various mechanisms, such as neutralizing pro-inflammatory cytokines, inhibiting intracellular signaling kinases (e.g., JAK inhibitors), or modulating leukocyte trafficking and activation (Source: StatPearls).